Welcome to LookChem.com Sign In|Join Free

CAS

  • or

153624-46-5

Post Buying Request

153624-46-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

153624-46-5 Usage

Chemical Properties

White to off-white or light tan powder

Uses

Different sources of media describe the Uses of 153624-46-5 differently. You can refer to the following data:
1. Reactant for:? ;Microwave-mediated click-chemistry synthesis of glyco-porphyrin derivatives with in vitro photo-cytotoxicity for application in photodynamic therapy1? ;Palladium-catalyzed oxidative cross-coupling reactions2? ;Ruthenium-catalyzed hydrogenation reactions3? ;Stereoselective rhodium-catalyzed arylation4? ;Palladium acetate catalyzed C-glycosidation5
2. suzuki reaction
3. 4-Isopropoxyphenylboronic Acid is used to synthesize potent cytotoxic analogues of the marine alkaloid Lamellarin D. It is also used to synthesize cyclooxygenase-2 (COX-2) inhibitors.

Check Digit Verification of cas no

The CAS Registry Mumber 153624-46-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,3,6,2 and 4 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 153624-46:
(8*1)+(7*5)+(6*3)+(5*6)+(4*2)+(3*4)+(2*4)+(1*6)=125
125 % 10 = 5
So 153624-46-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H13BO3/c1-7(2)13-9-5-3-8(4-6-9)10(11)12/h3-7,11-12H,1-2H3

153624-46-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (I0806)  4-Isopropoxyphenylboronic Acid (contains varying amounts of Anhydride)  

  • 153624-46-5

  • 5g

  • 840.00CNY

  • Detail
  • Alfa Aesar

  • (H52675)  4-Isopropoxybenzeneboronic acid, 97%   

  • 153624-46-5

  • 1g

  • 195.0CNY

  • Detail
  • Alfa Aesar

  • (H52675)  4-Isopropoxybenzeneboronic acid, 97%   

  • 153624-46-5

  • 5g

  • 386.0CNY

  • Detail
  • Alfa Aesar

  • (H52675)  4-Isopropoxybenzeneboronic acid, 97%   

  • 153624-46-5

  • 25g

  • 1544.0CNY

  • Detail

153624-46-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Isopropoxylphenylboronic acid

1.2 Other means of identification

Product number -
Other names 4-Isopropoxybenzeneboronic Acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:153624-46-5 SDS

153624-46-5Relevant articles and documents

Directed metalation?£?cross-coupling strategies. Total syntheses of the alleged and the revised phenanthrene natural product gymnopusin

Wang, Xin,Fu, Jian-Min,Snieckus, Victor

, p. 2680 - 2694 (2013/03/13)

The total synthesis of gymnopusin (2) is described. The originally assigned structure for gymnopusin 1a was found to be incorrect by total synthesis using the Directed ortho-Metalation (DoM)?£?Cross- Coupling?£?Directed remote Metalation (DreM) sequence, a demonstrable key strategy for the regioselective construction of the 9-phenanthrol core. The revised structure of gymnopusin (2) was confirmed by synthesis by adopting the same strategy but involving a key remote anionic Fries-rearrangement step. Both routes highlight methodologies and concepts which may be of value in the regiocontrolled synthesis of phenanthrenoids specifically and in complex polycyclic aromatics in general. Copyright

Heterocyclic compounds

-

, (2008/06/13)

The invention concerns pharmaceutically useful compounds of the formula I, in which A1, A2, A3, A4, B1, m, Ar, W, X, Y, Z and R1 have any of the meanings defined herein, and their pharmaceutically acceptable salts, and pharmaceutical compositions containing them. The novel compounds possess endothelin receptor antagonist activity and are useful, for example, in the treatment of diseases or medical conditions in which elevated or abnormal levels of endothelin play a significant causative role. The invention further concerns processes for the manufacture of the novel compounds and the use of the compounds in medical treatment.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 153624-46-5